Novavax COVID-19 Vaccine Adjuvanted from Germany
Novavax's COVID-19 vaccine is a protein-based vaccine with Matrix-M adjuvant, supplied in prefilled syringes for measured retail doses. It is an immunological product under tariff item 3002.15.00.
Duty Rate — Germany → Canada
0%
Import Tips
• Ensure the vaccine is authorized by Health Canada for import
• Declare it as an immunological product in measured doses for retail sale
• Keep the lot release certificate and storage temperature records for CBSA inspection